Enhancement of antiproliferative and proapoptotic effects of cadmium chloride combined with hSmac in hepatocellular carcinoma cells

Chemotherapy

Volumn 57, Issue 1, 2011, Pages 27-34

  Guo, Caixia ^a   Li, Yanbo ^a   Zhang, Haixia ^b,c   Wang, Zhicheng ^c   Jin, Minghua ^c   Zhang, Long ^c   An, Liping ^c   Hu, Guiqin ^c   Liu, Xiaomei ^c   Liu, Ying ^c   Du, Haiying ^c   Sun, Zhiwei ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Center for Disease Control of Shijingshan District   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Chemosensitivity; Combination chemotherapy; Cytotoxicity; In vitro; Tumor cells

Indexed keywords

ACRIDINE ORANGE; CADMIUM CHLORIDE; CASPASE 3; CASPASE 9; CYTOCHROME C; ETHIDIUM BROMIDE; LIPOFECTAMINE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CADMIUM CHLORIDE; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYTOCHROMES C; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MITOCHONDRIAL PROTEINS;

EID: 78650885834     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321031     Document Type: Article

References (37)

1. Tu QV, Okoli AS, Kovach Z, Mendz GL: Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. Future Microbiol 2009;4:1283-1301.
2. Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G: Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009;15:3210-3216.
3. Fang D, Bao Y, Li X, Liu F, Cai K, Gao J, Liao Q: Effects of iron deprivation on multidrug resistance of leukemic K562 cells. Chemotherapy 2010;56:9-16.
4. Waalkes MP, Diwan BA, Weghorst CM, Bare RM, Ward JM, Rice JM: Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol Appl Pharmacol 1991;110:327-335.
5. Waalkes MP, Diwan BA, Rehm S, Ward JM, Moussa M, Cherian MG, Goyer RA: Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. J Pharmacol Exp Ther 1996;277:1026-1033. (Pubitemid 27169017)
6. Piersma AH, Roelen B, Roest P, Haakmat-Hoesenie AS, van Achterberg TA, Mummery CL: Cadmium-induced inhibition of proliferation and differentiation of embryonal carcinoma cells and mechanistic aspects of protection by zinc. Teratology 1993;48:335-341. (Pubitemid 23313508)
7. Waalkes MP, Diwan BA: Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: role of apoptosis. Carcinogenesis 1999;20:65-70. (Pubitemid 29033846)
8. Waisberg M, Joseph P, Hale B, Beyersmann D: Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003;192:95-117. (Pubitemid 37311405)
9. Oh SH, Lim SC: A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation. Toxicol Appl Pharmacol 2006;212:212-223.
10. Rana SV: Metals and apoptosis: recent developments. J Trace Elem Med Biol 2008;22:262-284.
11. Fotakis G, Cemeli E, Anderson D, Timbrell JA: Cadmium chloride-induced DNA and lysosomal damage in a hepatoma cell line. Toxicol In Vitro 2005;19:481-489.
12. Lemarié A, Lagadic-Gossmann D, Morzadec C, Allain N, Fardel O, Vernhet L: Cadmium induces caspase-independent apoptosis in liver Hep3B cells: role for calcium in signaling oxidative stress-related impairment of mitochondria and relocation of endonuclease G and apoptosis-inducing factor. Free Radic Biol Med 2004;36:1517-1531. (Pubitemid 38746560)
13. Du H, Liu X, Liu Y, Jin M, Huang W, Sun Z: Inhibition effect of cadmium chloride on human hepatocellular carcinoma cells SMMC-7721. Chin J Public Health 2006;22:194-195.
14. Du H, Jin M, Liu Y, Liu XM, Wang W, Sun Z: Study on the anti-tumor effect of calcium chloride in vivo. Mod Prev Med 2008;35:3763-3765.
15. Cherian MG, Jayasurya A, Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 2003;533:201-209. (Pubitemid 37487869)
16. Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH: Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 2002;23:81-86. (Pubitemid 34213555)
17. Jayasurya A, Bay BH, Yap WM, Tan NG, Tan BK: Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels. Carcinogenesis 2000;21:1809-1812.
18. Du C, Fang M, Li Y, Li L, Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33-42.
19. Li R, Rüttinger D, Urba W, Fox BA, Hu HM: Targeting and amplification of immune killing of tumor cells by pro-Smac. Int J Cancer 2004;109:85-94. (Pubitemid 38160666)
20. Anguiano-Hernandez YM, Chartier A, Huerta S: Smac/DIABLO and colon cancer. Anticancer Agents Med Chem 2007;7:467-473. (Pubitemid 47099052)
21. Mao HL, Liu PS, Zheng JF, Zhang PH, Zhou LG, Xin G, Liu C: Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro. Pharmacol Res 2007;56:483-492. (Pubitemid 350137770)
22. Guo CX, Li YB, Du HY, Liu Y, Sun L, Jin MH, Sun ZW: Effects of over-expressed Smac gene coupling with cisplatin on proliferation and apoptosis of hepatocarcinoma cells (in Chinese). Zhonghua Gan Zang Bing Za Zhi 2008;16:674-677.
23. Guo CX, Li YB, Liu XM, Liu Y, Du HY, Gong SL, Sun ZW: Construction and expression of eukaryotic expression vector of full length human Smac gene. Chin J Public Health 2008;24:1328-1330.
24. Lou C, Wang M, Yang G, Cai H, Li Y, Zhao F, Yang H, Tong L, Cai B: Preliminary studies on anti-tumor activity of 2′,4′- dihydroxychalcone isolated from Herba Oxytropis in human gastric cancer MGC-803 cells. Toxicol In Vitro 2009;23:906-910.
25. Lim JY, Cho JY, Oh KJ, Choi SH, Lee SI, Jeung HC: Oxaliplatin combined with continuous infusion of 5-fluorouracil as firstline chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma. Chemotherapy 2009;55:200-206.
26. Yoo NJ, Kim HS, Kim SY, Park WS, Park CH, Jeon HM, Jung ES, Lee JY, Lee SH: Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. APMIS 2003;111:382-388. (Pubitemid 36560537)
27. Bao ST, Gui SQ, Lin MS: Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006;5:580-583.
28. Okano H, Shiraki K, Inoue H, Kawakita T, Saitou Y, Enokimura N, Yamamoto N, Sugimoto K, Fujikawa K, Murata K, Nakano T: Over-expression of Smac promotes TRAIL-induced cell death in human hepatocellular carcinoma. Int J Mol Med 2003;12:25-28.
29. McNeish IA, Bell S, McKay T, Tenev T, Marani M, Lemoine NR: Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res 2003;286:186-198. (Pubitemid 36566432)
30. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG, Bhalla K: Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 2002;99:3419-4326.
31. Fandy TE, Shankar S, Srivastava RK: Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer 2008;7:60.
32. Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT: Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Oncogene 2004;23:4523-4535.
33. Muñoz-Pinedo C, Guío-Carrión A, Goldstein JC, Fitzgerald P, Newmeyer DD, Green DR: Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc Natl Acad Sci USA 2006;103:11573-11578. (Pubitemid 44182493)
34. Pardo OE, Lesay A, Arcaro A, Lopes R, Ng BL, Warne PH, McNeish IA, Tetley TD, Lemoine NR, Mehmet H, Seckl MJ, Downward J: Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol Cell Biol 2003;23:7600-7610. (Pubitemid 37271459)
35. Gorka M, Godlewski MM, Gajkowska B, Wojewodzka U, Motyl T: Kinetics of Smac/DIABLO release from mitochondria during apoptosis of MCF-7 breast cancer cells. Cell Biol Int 2004;28:741-754. (Pubitemid 39550355)
36. Mendoza FJ, Henson ES, Gibson SB: MEKK1-induced apoptosis is mediated by Smac/Diablo release from the mitochondria. Biochem Biophys Res Commun 2005;331:1089-1098. (Pubitemid 40692471)
37. Lim ML, Chen B, Beart PM, Nagley P: Relative timing of redistribution of cytochrome c and Smac/DIABLO from mitochondria during apoptosis assessed by double immunocytochemistry on mammalian cells. Exp Cell Res 2006;312:1174-1184.